Abera Samuel Addisu, Molla Daniel Kassie, Abera Kirubel Addisu, Adisu Girma Damtew, Worku Misganaw Abere, Molla Yohannis Derbew
Department of Anatomic Pathology, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Department of Gynecology and Obstetrics, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Int Med Case Rep J. 2023 Sep 21;16:571-578. doi: 10.2147/IMCRJ.S432333. eCollection 2023.
Struma ovarii is an infrequent type of teratoma arising from the ovary accounting for only 2% of all ovarian teratomas. These tumors have a benign biology with rare malignant transformation in about 3% of cases. The most common malignant transformation that arises from struma ovarii is papillary thyroid carcinoma. These neoplasms act in the same way as those arising from the thyroid gland, but due to the rarity of their occurrence there is still a debate over therapeutic options. We present a case of a 41-year-old Ethiopian Para IX woman presented with abdominal swelling for four years, accompanied by dull pain, satiety, and weight loss. Her vital signs were normal, and her abdominal examination revealed a large abdominopelvic mass. Her CA-125 was elevated, and her blood count, organ function tests, and serum electrolyte levels were normal. Abdominal ultrasound revealed a complex abdominopelvic mass with cystic and solid components, possibly ovarian teratoma. The patient underwent surgery, revealing a 14 by 10 cm right ovarian mass and a 3×3 cm appendiceal mass. Subsequently, total abdominal hysterectomy, bilateral salpingo-oophorectomy, total omentectomy, and appendectomy was done. Histopathologic evaluation revealed follicular proliferation of enlarged cells, with no papillary growth pattern. The case was diagnosed as malignant struma ovarii, a follicular variant of papillary thyroid carcinoma (FVPTC) with secondary deposits on the appendix. A complete thyroidectomy was done after the histopathology diagnosis. Malignant struma ovarii is rare making it challenging to treat since there are no established prognosticating histopathologic or clinical characteristics. The tumor size and metastasis determine the surgical treatment scope. Large-scale investigations are essential for prognostication and treatment options considering pathologic traits.
卵巢甲状腺肿是一种罕见的卵巢畸胎瘤,仅占所有卵巢畸胎瘤的2%。这些肿瘤生物学行为良性,约3%的病例会发生罕见的恶性转化。卵巢甲状腺肿最常见的恶性转化是乳头状甲状腺癌。这些肿瘤的行为与起源于甲状腺的肿瘤相同,但由于其发生率低,治疗方案仍存在争议。我们报告一例41岁的埃塞俄比亚IX孕妇女,因腹部肿胀4年就诊,伴有钝痛、饱腹感和体重减轻。她的生命体征正常,腹部检查发现盆腔有一巨大肿块。她的CA-125升高,血常规、器官功能检查和血清电解质水平正常。腹部超声显示盆腔有一复杂肿块,有囊性和实性成分,可能为卵巢畸胎瘤。患者接受手术,发现右侧卵巢有一14×10 cm的肿块和一个3×3 cm的阑尾肿块。随后,进行了全腹子宫切除术、双侧输卵管卵巢切除术、全大网膜切除术和阑尾切除术。组织病理学评估显示细胞肿大呈滤泡样增生,无乳头状生长模式。该病例被诊断为恶性卵巢甲状腺肿,即乳头状甲状腺癌滤泡变体(FVPTC),阑尾有继发性转移。组织病理学诊断后进行了全甲状腺切除术。恶性卵巢甲状腺肿罕见,由于没有既定的预后组织病理学或临床特征,治疗具有挑战性。肿瘤大小和转移决定手术治疗范围。考虑到病理特征,大规模研究对于预后评估和治疗选择至关重要。